Description: The crisis has spread due to a systematic failure of the regulatory system. Over the last 20 years, regulations that fostered market stability were eliminated and new financial instruments were allowed to propagate without any real oversight. Instead of bailing out weak financial firms, we should be liquidating them. All doubtful asses need to be written-downs. We need accurate and transparent accounting.

Description: This 1979 session is about the New Valuation Mortality Tables for Individual Life Insurance. Topics included: I. The Recommendation of Sex-distinct Tables 2. The Development of Basic Tables - Data Selection, Construction, Graduation 3. Margins and the Development of Loaded Tables 4. Implications for the Industry

Description: From the 1986 Valuation Actuary Symposium, held in Washington DC in October 1986 Discussion of cash flow testing to assess level of C-1,C-2, and C-3 risk. Also, update on regulatory and legislative issues in Canada pertaining to the Valuation Actuary, reserves, and risk based capital

Description: This session from the 1992 Valuation Actuary Symposium focuses on Risk-Based Capital issues and the important points concerning A.M. Best's view of leverage and capital adequacy in the review process.

Description: This session from the 1993 Valuation Actuary Symposium looks at an overview of developments in 1993 including a regulator's viewpoint of various valuation actuary issues, an update on the valuation actuary and health insurance, current developments in reinsurance that should be considered in the valuation process and a sample actuarial opinion and memorandum.

Description: 1996 Valuation Actuary Symposium. Questions asked and answered included: 1. What do regulators expect or want as far as asset adequacy analysis for shorter-term liabilities such as IBNR? 2. What responsibility does the appointed actuary have in verifying reserves for reinsured business? 3. If the assets for the market value adjusted annuity are held in a separate account and valued at market, what rates should be used to present value the projected guaranteed benefits? 4. May a company perform the cash-flow testing based on the low level of reserves held in the domiciliary state rather than the higher reserve actually held in the state with the special state in filing? 5. Have there been any situations where an opining valuation actuary has been held personally responsible?

Description: 1998 Valuation Actuary Symposium. The panelists discussed product design of Equity Indexed products, interest crediting strategies, investment risks, hedging issues, and internal controls and risk management for companies getting started in the derivatives market.

Description: 1998 Valuation Actuary Symposium. Dynamic Financial Condition Analysis is analysis and sensitivity testing and stress testing. Stated another way it is measuring the ability of a company to support future operations. The panelists provided an update on recent Society research that has been done and examples in practice.

Description: Discussion of leading edge companies. Topics included: 1. How they got there 2. Lessons to be learned 3. Financial reporting issues faced by actuaries and others involved with companies that have failed or are close to statutory insolvency 4. Turning it around- strategies for future success.

Description: 1992 SOA Annual Meeting, Washington, D.C. This session on cash-flow testing for product actuaries covered the following topics: 1. Guidance notes designed to help in writing up reports on cash-flow testing. 2. Investment strategies in product design. 3. Surplus requirements.